Clinical Trial Update: Norepinephrine Infusion Versus Midodrine & Octreotide in Patients With Hepatorenal Syndrome Type 1. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing norepinephrine infusion with midodrine and octreotide for hepatorenal syndrome type 1 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatorenal Syndrome Type 1
• Renal Impairment

Drugs mentioned

• Midodrine (Midodrine)
• OCTREOTIDE (OCTREOTIDE ACETATE)
• norepinephrine infusion (norepinephrine)

Snippet

Sponsor: National Hepatology & Tropical Medicine Research Institute | Conditions: Renal Impairment in Hepatorenal Syndrome | Phase 4 | Status: COMPLETED